The 6 months i was talking about was the time it took AFTER MHRA told Biotec they supported Woulgan as a medical device under class III, rule 13 until the CE-mark was finally approved.
Biotec started the process with MHRA in may 2012!
Now the product is in the hands of Smith&Nephew, at least for a while.
TIS Price at posting:
29.5¢ Sentiment: None Disclosure: Not Held
